Pediatric Vaccines Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Pediatric Vaccines 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t es t  r ep o r t  by  I M ARC  G r oup ,  t i t l ed  "P ed i a t r i c  V acc i nes  M arke t :  
G l o ba l  I ndu st ry  T re nds ,  Sh are ,  S i ze ,  G row t h ,  O pp or t u n i t y  an d  Fo recas t  20 24 -
2032 , "  t he  g loba l  ped ia t r i c  vacc ines  m ar ke t  s i ze  r eache d  US $  37 . 0  B i l l i o n  i n  2023 .
Ped ia t r i c  vac c ines  a r e  gen er a l l y  ad m in i s t e r ed  t o  ch i l d r e n  an d  i n f an t s  t h a t  a r e  
Report r eco m m ended  by  o r ga n i za t i ons  and  agen c ies .  The y  a r e  an  i n t eg r a l  pa r t  o f  
im m un iza t i on  t ha t  he lp  t he  bod y  b ecom e r es i s t an t  t o  num er ou s  d i sease - cau s ing  
Highlight and agen t s ,  such  as  v i r uses  and  ba c t e r i a .  Th ey  a r e  w i de l y  a va i l ab le  i n  m u l t i p l e  f o r m s  t ha t  va r y  on  t he  b as i s  o f  t he i r  r ou t e  o f  a dm in is t r a t i on  a nd  ch i l d r e n ’ s  ag e  an d  hea l t h .  
They  i nc lu de  l i ve ,  i na c t i va t ed ,  con ju ga t e ,  r ec om b in an t ,  t ox o id  an d  sub un i t s  t ha t  
Description ens ur e  lo ng - la s t i ng  p r o t ec t i on  ag a ins t  t he  pa t hog ens .  Som e o f  t he  com m o n ly  
adm in i s t e r ed  ped ia t r i c  vac c ines  a r e  H epa t i t i s  B ,  Ro t av i r us ,  Pneu m oco cca l  
con ju ga t e ,  I n f l uenz a ,  M eas le s ,  Va r i ce l l a ,  Te t anus  and  M en ingoco cca l .
Reque st  f o r  a  PDF  sam pl e  o f  t h i s  re por t :  
h t t p s : / / www. im ar c g r ou p . com / ped ia t r i c - vac c ines - m ar k e t / r eque s t sam p le
Report Description
G l ob a l  Pe d i a t r i c  Vacc i nes  M ark e t  T rend s :
The  g loba l  m a r ke t  i s  p r im ar i l y  d r i ven  by  t he  g r ow in g  p r eva l ence  o f  c h r on i c  d i s ease s  am ong  t he  pe d ia t r i c  pop u la t i on .  Th i s  
can  be  a t t r ib u t ed  t o  t he  i nc r eas in g  b i r t h  r a t e s  and  t h e  r i s i ng  a war e ness  am on g  pa r en t s .  A lon g  w i t h  t h i s ,  num er ous  
i n i t i a t i ves  unde r t ak en  by  v a r i ous  gov e r nm en t  an d  non - gov e r nm en t  o r g an i za t i ons  o f  seve r a l  coun t r i es  t o  r a i se  awar eness  
r ega r d ing  t he  im po r t a nce  o f  ped ia t r i c  vacc i nes  an d  con duc t  v acc in a t i on  d r i ves  a r e  c r ea t in g  a  po s i t i ve  m ar ke t  ou t l ook .  I n  
add i t i o n  t o  t h i s ,  t he  g r ow i ng  i nve s t m e n t s  by  pu b l i c  and  p r i v a t e  a genc i es  i n  e x t en s i ve  r esea r ch  and  d eve lo pm e n t  ( R& D)  
ac t i v i t i es  i n  t he  f i e l d  o f  l i f e  sc ience s  an d  gene t i c  eng ine e r ing  a r e  im pac t i ng  t he  m ar k e t  g r ow t h  f avo r ab l y .  
Fu r t h e r m o r e ,  c on t i n uous  t echn o log i ca l  advan cem en t s  in  t he  va cc ina t i on  p r o duc t i on  p r ocess es  a r e  s ig n i f i ca n t l y  sup po r t i n g  
t he  p r o duc t  d em and  o n  t he  g lob a l  l eve l .  T he  m ar ke t  i s  f u r t he r  d r i v en  by  seve r a l  i m p r o vem e n t s  i n  t h e  s upp ly  cha in  
p r oc esses .  O t he r  f a c t o r s ,  i nc lud ing  con t in ua l  d eve lop m en t s  i n  t he  he a l t hca r e  i n f r as t r uc t u r e ,  t he  es t ab l i sh m en t  o f  m ed ica l  
f ac i l i t i e s  ac r oss  r u r a l  a nd  g eog r a ph ica l  ex t e nded  l oca t i ons ,  and  c on t i n uous  p r odu c t  i nno va t i on s ,  a r e  a l so  pos i t i ve l y  
i n f l uen c ing  t he  m ar k e t .
Vi ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / pe d i a t r i c - v acc i n es - m ark e t
Breakup by Type:
• Multivalent
• Monovalent
 
Breakup by Technology:
• Conjugate
• Live Attenuated
Report 
• Inact ivated
Segmentation • Subunit
• Toxoid
• Others
Breakup by Application:
• Infectious Disease
• Cancer
• Al lergy
• Others
Breakup by Region:
• North America
• Asia-Pacifi c
Report 
• Europe
Segmentation • Latin America
• Middle East and Afr ica
• Abbott Laboratories
• Bio-Med Private Limited
• Dai ichi Sankyo Company Limited
• GSK plc
Competitive 
• Indian Immunologicals Limited (National 
Landscape Dairy Development Board)
• Merck & Co. Inc.
with Key 
• Mitsubishi  Tanabe Pharma Corporation 
Players (Mitsubishi  Chemical Holdings Corporation)
• Panacea Biotec Limited
• Pfi zer Inc.
• Sanofi  S.A.
• Sinovac Biotech Ltd.
What was the size of the global pediatric vaccines 
market in 2023?
What is the expected growth rate of the global 
pediatric vaccines market during 2024-2032?
What are the key factors driving the global 
Key pediatric vaccines market?
Questions What has been the impact of COVID-19 on the 
global pediatric vaccines market?
Answered in 
What is the breakup of the global pediatric 
the Report vaccines market based on the type?
What is the breakup of the global pediatric 
vaccines market based on the technology?
What are the key regions in the global pediatric 
vaccines market?
Who are the key players/companies in the global 
pediatric vaccines market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  P e d i a t r i c  V a c c i n e s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  T y p e
    6 . 1     M u l t i v a l e n t
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     M o n o v a l e n t
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T e c h n o l o g y
    7 . 1     C o n j u g a t e
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
 7 . 2     L i v e  A t t e n u a t e d
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     I n a c t i v a t e d
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     S u b u n i t
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     T o x o i d
Table of         7 . 5 . 1  M a r k e t  T r e n d s        7 . 5 . 2  M a r k e t  F o r e c a s t
    7 . 6     O t h e r s
        7 . 6 . 1  M a r k e t  T r e n d s
Contents         7 . 6 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     I n f e c t i o u s  D i s e a s e
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     C a n c e r
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     A l l e r g y
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
 8 . 4     O t h e r s
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /p ed i a t r i c -va c c i nes -ma rke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]